Meagan Thistle

Quiz
Quiz
What percentage of people experience hypomanic symptoms during an MDD episode?
01/15/2025
According to a recent study published in the Journal of Affective Disorders, what percentage of people experienced hypomanic symptoms during a major depressive disorder (MDD) episode?
According to a recent study published in the Journal of Affective Disorders, what percentage of people experienced hypomanic symptoms during a major depressive disorder (MDD) episode?
According to a recent study...
01/15/2025
Psych Congress Network
DSM-5
Quiz
How does the chronicity of depressive symptoms affect MDD treatment and outcomes?
12/11/2024
12/11/2024
Psych Congress Network
Conference Coverage
Retreatment With R-CHOP-Like Therapy Effective in Late-Relapse DLBCL
12/07/2024
In patients with late-relapse DLBCL, a retreatment strategy with R-CHOP-like therapy is a reasonable option and results in durable remission in a high proportion of patients, according to a retrospective study presented at the 2024 ASH Annual...
In patients with late-relapse DLBCL, a retreatment strategy with R-CHOP-like therapy is a reasonable option and results in durable remission in a high proportion of patients, according to a retrospective study presented at the 2024 ASH Annual...
In patients with late-relapse...
12/07/2024
Oncology
Depression
News
Study Reveals Anhedonia Impact on Symptom Severity and Treatment Outcomes in Patients With MDD
11/22/2024
A rstudy presented in a poster at Psych Congress 2024 in Boston, Massachusetts, aimed to understand the characteristics and treatment patterns of patients with MDD who experience prominent anhedonia compared to those who do not or who have...
A rstudy presented in a poster at Psych Congress 2024 in Boston, Massachusetts, aimed to understand the characteristics and treatment patterns of patients with MDD who experience prominent anhedonia compared to those who do not or who have...
A rstudy presented in a poster...
11/22/2024
Psych Congress Network
News
First and Only Oral NDMA Receptor Antagonist for MDD Can Now Be Prescribed
10/27/2022
Extended-release dextromethorphan HBr-bupropion HCl (Auvelity™) approved for the treatment of MDD.
Extended-release dextromethorphan HBr-bupropion HCl (Auvelity™) approved for the treatment of MDD.
Extended-release...
10/27/2022
Psych Congress Network
a doctor holds a generic orange pill bottle
News
Zenzedi CII 30 mg Tablets Recalled Over Mislabeling Concerns
01/29/2024
zurity Pharmaceuticals, Inc. has issued a voluntary recall of 1 lot of Zenzedi CII 30 mg tablets after a Nebraska pharmacist discovered carbinoxamine maleate, an antihistamine, in a bottle labeled as Zenzedi 30 mg.
zurity Pharmaceuticals, Inc. has issued a voluntary recall of 1 lot of Zenzedi CII 30 mg tablets after a Nebraska pharmacist discovered carbinoxamine maleate, an antihistamine, in a bottle labeled as Zenzedi 30 mg.
zurity Pharmaceuticals, Inc. has...
01/29/2024
Neurology
News
Tardive Dyskinesia Creates Physical, Psychological, and Social Burden
11/12/2021
Tardive dyskinesia negatively impacts patients’ physical functioning, mental well-being, and social activities—even in patients with self-assessed mild-to-moderate symptoms.
Tardive dyskinesia negatively impacts patients’ physical functioning, mental well-being, and social activities—even in patients with self-assessed mild-to-moderate symptoms.
Tardive dyskinesia negatively...
11/12/2021
Psych Congress Network
News
With Pediatric ADHD Diagnosis, Lower Quality of Life Measures Reported
02/20/2023
A pediatric ADHD diagnosis was associated with negative impacts on some quality of life (QOL) measures, study finds.
A pediatric ADHD diagnosis was associated with negative impacts on some quality of life (QOL) measures, study finds.
A pediatric ADHD diagnosis was...
02/20/2023
Psych Congress Network
Tinnitus
News
Multilocus Sequential rTMS Shows Promise in Treating Tinnitus, Especially in Absence of Comorbid Depression
03/06/2024
Multilocus rTMS reduced tinnitus symptom severity in both patients with and without comorbid MDD in a recent open-label treatment study.
Multilocus rTMS reduced tinnitus symptom severity in both patients with and without comorbid MDD in a recent open-label treatment study.
Multilocus rTMS reduced tinnitus...
03/06/2024
Psych Congress Network
News
Gender-Affirming Care Associated With Positive Mental Health Outcomes in Adolescents
03/30/2022
Access to gender-affirming medical interventions was associated with 60% lower odds of depression and 73% lower odds of self-harm or suicidal thoughts in transgender and nonbinary youths (TNB) over 1 year.
Access to gender-affirming medical interventions was associated with 60% lower odds of depression and 73% lower odds of self-harm or suicidal thoughts in transgender and nonbinary youths (TNB) over 1 year.
Access to gender-affirming...
03/30/2022
Psych Congress Network

Upcoming Events

February 2 ⁠–⁠ February 5
LLM Winter Symposium
February 7 ⁠–⁠ February 9
Western AF Symposium
February 27 ⁠–⁠ March 1
DCLF
March 17 ⁠–⁠ March 19
GD Solid Tumors
March 22 ⁠–⁠ March 23
NP Institute
March 27 ⁠–⁠ March 30
TCIV
March 31 ⁠–⁠ April 2
Rx summit logo
April 21 ⁠–⁠ April 24
Symposium on Advanced Wound Care
April 30 ⁠–⁠ May 4
WoundCon
May 1 ⁠–⁠ May 3
See Full Calendar

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use